CPTx advances new treatment paradigms for a spectrum of medical challenges, with an initial focus on infectious diseases.
Through programmable DNA nanofabrication technology, CPTx builds advanced therapeutic agents, offering unprecedented options for designing solutions for unmet medical needs.
Infectious Diseases
Infectious Diseases
Infectious Diseases
Preclinical Validation Phase
Infectious Diseases
Discovery Phase
In Development
In Development
Capture different types of viruses, regardless of form and size.
Compatibility with a wide range of virus-binding molecules such as antibodies, peptides, and polymers.
Robust trapping of viruses, offering resistance against viral mutations.
Disable many viruses using the same formulation.
Suppresses the viral reproduction as a cell entry inhibitor.
Intravenous, subcutaneous or intranasal administration for prevention or treatment of acute infections.
Built from biological material, does not interfere with host metabolism.
The system can carry additional effector functionalities to further support pathogen removal.